Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2011 1
2012 13
2013 102
2014 908
2015 1492
2016 1678
2017 1730
2018 1854
2019 984
2020 27
Text availability
Article attribute
Article type
Publication date

Search Results

7,569 results
Results by year
Filters applied: . Clear all
Page 1
Non-alcoholic fatty liver disease.
Neuschwander-Tetri BA. BMC Med 2017 - Review. PMID 28241825 Free PMC article.
Non-alcoholic fatty liver disease has emerged a major challenge because of it prevalence, difficulties in diagnosis, complex pathogenesis, and lack of approved therapies. ...This overview briefly summarizes the most recent data on the pathophysiology, diagnosis, and treatment of non-alcoholic fatty liver disease. ...
Non-alcoholic fatty liver disease has emerged a major challenge because of it prevalence, difficulties in
Non-Alcoholic Fatty Liver Disease.
Engin A. Adv Exp Med Biol 2017 - Review. PMID 28585211
Non-alcoholic fatty liver disease (NAFLD) is in parallel with the obesity epidemic and it is the most common cause of liver diseases. ...Insulin resistance is the major mechanism in the development and progression of NAFLD/Non-alcoholic steatohepatitis (NASH). Metabolic oxidative stress, autophagy, and inflammation induce NASH progression. ...
Non-alcoholic fatty liver disease (NAFLD) is in parallel with the obesity epidemic and it is the most com
Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters.
Cobbina E and Akhlaghi F. Drug Metab Rev 2017 - Review. PMID 28303724 Free PMC article.
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver disorders. It is defined by the presence of steatosis in more than 5% of hepatocytes with little or no alcohol consumption. ...
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver disorders. It is defined by the p
Fatty liver disease.
Brody H. Nature 2017. PMID 29168811
Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.
Younossi ZM, et al. Hepatology 2016 - Review. PMID 26707365
Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. We estimated the global prevalence, incidence, progression, and outcomes of NAFLD and nonalcoholic steatohepatitis (NASH). ...Incidence risk ratios for liver-specific and overall mortality for NAFLD were 1.94 (range, 1.28-2.92) and 1.05 (range, 0.70-1.56). ...
Nonalcoholic fatty liver disease (NAFLD) is a major cause of liver disease worldwide. We estimated the gl …
Future therapy for non-alcoholic fatty liver disease.
Issa D, et al. Liver Int 2018 - Review. PMID 29427492
Non-alcoholic fatty liver disease is a leading cause of chronic liver disease and can lead to cirrhosis, hepatocellular cancer and end stage liver disease. ...There are currently no approved therapies for non-alcoholic fatty liver disease. This review summarizes ongoing efforts to establish the treatment of non-alcoholic steatohepatitis the progressive form of non-alcoholic fatty liver disease. ...
Non-alcoholic fatty liver disease is a leading cause of chronic liver disease and can lead
[Treatment of non-alcoholic fatty liver disease].
Heebøll S, et al. Ugeskr Laeger 2018 - Review. PMID 30064623 Danish.
Non-alcoholic fatty liver disease and especially non-alcoholic steatohepatitis (NASH) and fibrosis are associated with severe liver disease and increased cardiovascular risk. ...
Non-alcoholic fatty liver disease and especially non-alcoholic steatohepatitis (NASH) and f
Pathophysiology of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis.
Manne V, et al. Clin Liver Dis 2018 - Review. PMID 29128059
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver disorders ranging from hepatic steatosis to nonalcoholic steatohepatitis (NASH) and ultimately may lead to cirrhosis. ...Fatty liver can progress to NASH in a significant proportion of subjects. NASH is a necroinflammatory liver disease governed by multiple pathways that are not completely elucidated. ...
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of liver disorders ranging from hepatic steatosi …
Nonalcoholic fatty liver disease: a systematic review.
Rinella ME. JAMA 2015 - Review. PMID 26057287
IMPORTANCE: Nonalcoholic fatty liver disease and its subtype nonalcoholic steatohepatitis affect approximately 30% and 5%, respectively, of the US population. ...Cirrhosis, the third leading cause of death in patients with nonalcoholic fatty liver disease, is predicted to become the most common indication for liver transplantation. ...
IMPORTANCE: Nonalcoholic fatty liver disease and its subtype nonalcoholic steatohepatitis affect approximately 30% and …
7,569 results
Jump to page
Feedback